Anti-Parkinson's disease drugs Pharmacokinetics Chemical property Uses Production method
ChemicalBook > CAS DataBase List > Entacapone

Entacapone

Anti-Parkinson's disease drugs Pharmacokinetics Chemical property Uses Production method
Product Name
Entacapone
CAS No.
130929-57-6
Chemical Name
Entacapone
Synonyms
(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide;Comtan;Comtes; OR-611;Comtess;HSDB8251;HSDB 8251;HSDB-8251;ENTACAPONE;E Entacapone
CBNumber
CB5726435
Molecular Formula
C14H15N3O5
Formula Weight
305.29
MOL File
130929-57-6.mol
More
Less

Entacapone Property

Melting point:
162-1630C
Boiling point:
526.6±50.0 °C(Predicted)
Density 
1.392±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
DMSO: soluble20mg/mL, clear
pka
pKa ~4.5(at 25℃)
form 
powder
color 
white to light brown
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 1 month.
InChIKey
JRURYQJSLYLRLN-BJMVGYQFSA-N
CAS DataBase Reference
130929-57-6(CAS DataBase Reference)
More
Less

Safety

WGK Germany 
3
HS Code 
2926900005
Hazardous Substances Data
130929-57-6(Hazardous Substances Data)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P337+P313IF eye irritation persists: Get medical advice/attention.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML0654
Product name
Entacapone
Purity
≥98% (HPLC)
Packaging
10mg
Price
$77.4
Updated
2024/03/01
Cayman Chemical
Product number
14153
Product name
Entacapone
Purity
≥98%
Packaging
10mg
Price
$44
Updated
2024/03/01
Cayman Chemical
Product number
14153
Product name
Entacapone
Purity
≥98%
Packaging
25mg
Price
$67
Updated
2024/03/01
Sigma-Aldrich
Product number
Y0001249
Product name
Entacapone
Purity
European Pharmacopoeia (EP) Reference Standard
Packaging
y0001249
Price
$220
Updated
2024/03/01
Sigma-Aldrich
Product number
SML0654
Product name
Entacapone
Purity
≥98% (HPLC)
Packaging
50mg
Price
$257
Updated
2024/03/01
More
Less

Entacapone Chemical Properties,Usage,Production

Anti-Parkinson's disease drugs

Entacapone is an anti-Parkinson's disease drug which is successfully developed by Orion Pharma company in Swedish. It is a highly selective potent catechol-O-methyltransferase (COMT) inhibitor, rarely penetrating the blood-brain barrier, and primarily acting in the intestinal tract. It is dose-dependent to decrease levels of 3-OMD in serum and the brain, increasing levodopa, dopamine and DOPAC levels in the brain and significantly reducing the dose which is required to increase dopamine concentration in striatal. Levodopa and carbidopa combining with COMTI can significantly increase the bioavailability of levodopa (3-4 times). Activity of COMTI in red blood cell is reversible. When in 800mg dose, the maximum inhibitory activity is up to 82%, so Entacapone combines with levodopa and carbidopa, which can be used for adjuvant therapy of idiopathic Parkinson's disease.

Pharmacokinetics

This product is rapid oral absorption, the bioavailability is a dose-dependent with the range of 30% to 45%. In the range of 5~800 mg, pharmacokinetics of Entacapone (abbreviation: Ent) is linear, peak plasma concentration is related to AUC and dose. Food does not affect the absorption of this product, 98% Ent combines with plasma albumin, rarely distributing in tissues. In patients with Parkinson disease (abbreviated: PD), and is required to take levodopa/carbidopa, the peak concentration of Ent arrives within 1~2h. The rate of Ent through the blood-brain barrier is low, the plasma elimination half-life is 1.5~3.5h. After oral administration, Ent (E-configuration) is metabolized to Z-isomer in the blood and is present in plasma and red blood cells. Z-isomer has little impact on the clinical efficacy. Its drug-time curve is similar to Ent. Z-Ent accounts for about 5% of the total AUC. Ent and Z-Ent are acidified by glucose in the liver. After metabolism of Ent: 10% excreted in the urine, 90% of Ent excreted in the feces, only 0.2% excreted in the urine in phony drugs. While taking levodopa in PD patients, and oral Ent 200 mg after elimination half-life of about 1 h, the body has no savings.
Pharmacokinetic study shows that in healthy persons and patients with PD, Ent can increase the bioavailability of levodopa. In the short-term PD patients taking Ent, AUC of levodopa increase 25%, while the long-term taking Ent can increase 50%. AUC of 3-OMD relatively reduces 60%. In these studies, they found that plasma peak time of levodopa will be extended. Single dose of Entacapone (while not taking levodopa/carbidopa), in patients with liver disease, the patient's AUC and Cmax is 2 times of the patients with normal liver function. We should adjust the dosage of the patient. In patients with mild to moderate kidney disease, it is not necessary to adjust the dosage. Kidney patients receiving dialysis can extend dosing interval.
The above information is edited by the Chemicalbook of Liu Yujie.

Chemical property

Crystals, melting point 162--163 ℃.

Uses

As COMT inhibitors, it is used to treat Parkinson's disease.

Production method

1.83 g 3,4-dihydroxy-5-nitrobenzaldehyde and 1.5g N, N-diethyl-cyanoacetamide and a catalytic amount of piperidine acetate are dissolved in 40ml of dry ethanol , followed by stirring overnight , 2.23 g crude product is obtained, yield 73%, melting point 153~156 ℃.
Heated at 90 ℃, the 3.0 kg crude product is dissolved in 8.0kg acetic acid (or formic acid) containing 80 g HBr (or 40gHCl).It is slowly cooled to 20 ℃, and stirred at this temperature for 20h, then at 15 ℃ stirred for 6h. The precipitated crystals were collected by filtration, carefully washed with cool (4 ℃) 1L toluene-acetic acid (1: l v/v) mixed solution, and washed with 1L cold toluene. It is dried at 45 ℃under vacuum and 2.4kg crystalline pure Entacapone is obtained, yield 80%, melting point 162-163 ℃.

Description

Entacapone was introduced in Finland, Germany and Sweden as an adjunctive treatment with L-dopa in Parkinson’s disease. Entacapone is the second drug in its class to reach the market; it can be obtained by basecatalyzed condensation of the corresponding benzaldehyde with a cyanoacetamide. Entacapone is a highly selective and orally-active catechol-0- methyltransferase (COMT) inhibitor ; by inhibiting metabolism of L-dopa when given as an adjuvant in patients with Parkinson’s disease, Entacapone markedly prolongs the effects of L-dopa and improves its bioavailability. Results from clinical studies showed that 200mglday Entacapone coadministered with L-dopa lowered the dose of the latter required to reduce fluctuations in motor performance.

Chemical Properties

Yellow Crystalline Solid

Originator

Orion Pharma (Finland)

Uses

(E)-Isomer of Entacapone polymorphic form A. Peripherally acting inhibitor of catechol-O-methyl transferase (COMT), an enzyme involved in the metabolism of catecholamine neurotransmitters and related drugs. Antiparkinsonian

Uses

antiparkinsinian;catechol-O-methyl transferase inhibitor

Uses

This compound belongs to the cinnamic acid amides. These are amides of cinnamic acids. Used as an adjunct to levodopa / carbidopa in the symptomatic treatment of patients with idiopathic Parkinson's Disease who experience the signs and symptoms of end-of-

Definition

ChEBI: A monocarboxylic acid amide that is N,N-diethylprop-2-enamide in which the hydrogen at position 2 is substituted by a cyano group and the hydrogen at the 3E position is substituted by a 3,4-dihydroxy-5 nitrophenyl group.

Manufacturing Process

N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide (2- Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl).
A solution containing 1.83 g of 3,4-dihydroxy-5-nitrobenzaldehyde, 1.5 g of N,N-diethylcyanoacetamide and catalytic amount of piperidine acetate in 40 ml of dry ethanol was refluxed over night. After cooling the solvent was evaporated in vacuo and the residue was recrystallized from waterdimethylformamide. Yield of desired product was 2.23 g (73%), melting point 153°-156°C.

brand name

Comtan(Orion);Comtess.

Therapeutic Function

Antiparkinsonian

General Description

Entacapone, (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide (Comtan),is a nitrocatechol that is practically insoluble in water (pKa＝4.50). Entacapone is rapidly absorbed after oral administrationand does not cross the BBB. Entacapone does not distributewidely into tissues because of its high plasma proteinbinding and it is completely metabolized before excretion.The main metabolic pathway is by isomerization to the cisisomerfollowed by direct glucuronidation of the parent andthe cis-isomer. The glucuronide conjugates are inactive.Entacapone is eliminated in the feces (90%) and urine (10%).Entacapone is indicated as an adjunct to levodopa/carbidopato treat patients with idiopathic PD who experience the signsand symptoms of end-of-dose wearing off.

Biochem/physiol Actions

Entacapone is a catechol-O-methyl transferase (COMT) inhibitor. Used in treatment of Parkinson′s disease, entacapone is administered with L-DOPA to inihibit COMT from converting L-DOPA into a compound that cannot cross the blood brain barrier.

Drug interactions

Potentially hazardous interactions with other drugs
Anticoagulants: enhances anticoagulant effect of warfarin
Antidepressants: use with caution in combination with moclobemide, tricyclics and venlafaxine; avoid with MAOIs.
Dopaminergics: possibly enhances effects of apomorphine; possibly reduces concentration of rasagiline; max dose of selegiline is 10 mg in combination.

Metabolism

Entacapone undergoes extensive first-pass metabolism to form glucuronide metabolites.
It is eliminated mainly in the faeces with about 10-20% being excreted in the urine, mainly as glucuronide conjugates

storage

Store at RT

References

1) Forsberg?et al.?(2003),?Pharmacokinetics and pharmacodynamics of entacapone and tolcapone after acute and repeated administration: a comparative study in the rat; J. Pharmacol. Exp. Ther.,?304?498 2) Merello?et al. (1994),?Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson’s disease; J. Neurol. Neurosurg. Psychiatry,?57?186 3) Giovanni?et al. (2010),?Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of alpha-synuclein and beta amyloid and protect against amyloid-induced toxicity; J. Biol. Chem.,?285?14941 4) Chen?et al. (2016),?Entacapone is an Antioxident More Potent than Vitamin C and Vitamin E for Scavenging of Hypochlorous Acid and Peroxynitrite, and the Inhibition of Oxidative Stress-induced Cell Death; Med. Sci. Monit.,?22?687

Entacapone Preparation Products And Raw materials

Raw materials

2-Cyanoacetamide 3-Nitro-4,5-dihydroxybenzaldehyde Piperidinium acetate 3-Methylphenylacetic acid

Preparation Products

More
Less

Entacapone Suppliers

Brazil 1 Canada 8 China 281 Cyprus 1 Czech Republic 1 Europe 2 Finland 2 France 3 Germany 3 Greece 1 India 83 Italy 6 Japan 1 Malaysia 1 Nepal 1 Philippines 1 Poland 1 Slovenia 1 South Korea 3 Spain 1 United Arab Emirates 1 United Kingdom 16 United States 53 Uruguay 1 Global 473
Jai Radhe Sales
Tel
+(91)-(79)-26431096/65255722
Fax
+(91)-(79)-26569884
Email
info@jairadhesales.com
Country
India
ProdList
397
Advantage
60
Manus Aktteva
Tel
--
Fax
--
Email
info@manusaktteva.in
Country
India
ProdList
581
Advantage
34
Chemicea Pharmaceuticals Pvt Ltd
Tel
--
Fax
--
Email
sales@chemicea.com
Country
India
ProdList
825
Advantage
58
CLEANCHEM LABORATORIES LLP
Tel
--
Fax
--
Email
sales4@cleanchemlab.com
Country
India
ProdList
325
Advantage
58
Jigs Chemical Limited
Tel
--
Fax
--
Email
info@jigschemical.com
Country
India
ProdList
235
Advantage
58
PIRAMAL PHARMA LTD
Tel
--
Fax
--
Email
corporate.communication@piramal.com
Country
India
ProdList
28
Advantage
58
Sun Pharmaceutical Industries Ltd.
Tel
--
Fax
--
Email
SunPharma.IndiaBusiness@sunpharma.com
Country
India
ProdList
99
Advantage
58
Avience chemicals and pharmaceuticals
Tel
--
Fax
--
Email
expoavience@gmail.com
Country
India
ProdList
180
Advantage
58
Argos International
Tel
--
Fax
--
Country
India
ProdList
154
Advantage
58
Sai Prathyu Marketing
Tel
--
Fax
--
Country
India
ProdList
162
Advantage
58
Placid Pharmachem
Tel
--
Fax
--
Email
parikshitjain@vsnl.com
Country
India
ProdList
115
Advantage
58
Maas Pharma Chemicals
Tel
--
Fax
--
Email
info@maaspharmachemicals.com
Country
India
ProdList
1607
Advantage
58
Prism Consultancy
Tel
--
Fax
--
Email
info@prismconsultancy.biz
Country
India
ProdList
66
Advantage
58
Opulent Pharma
Tel
--
Fax
--
Country
India
ProdList
810
Advantage
58
Vyshno Bio Sciences
Tel
--
Fax
--
Email
info@vyshnobio.com
Country
India
ProdList
239
Advantage
58
Chempro Pharma Pvt. Ltd.
Tel
--
Fax
--
Email
ankitsehgal@chemprogroup.net
Country
India
ProdList
170
Advantage
58
Pharmaffiliates Analytics & Synthetics (P) Ltd.
Tel
--
Fax
--
Email
g@pharmaffiliates.com
Country
India
ProdList
631
Advantage
58
Merix Laboratories Pvt. Ltd
Tel
--
Fax
--
Email
info@merixindia.com
Country
India
ProdList
132
Advantage
58
Shagun Pharmaceuticals
Tel
--
Fax
--
Email
info@shagunpharma.com
Country
India
ProdList
193
Advantage
58
Kkyemistry (india) Pvt., Ltd.
Tel
--
Fax
--
Email
marketing@kyemistryindia.com
Country
India
ProdList
163
Advantage
58
Divis Laboratories Ltd.
Tel
--
Fax
--
Country
India
ProdList
147
Advantage
58
Samex Overseas
Tel
--
Fax
--
Country
India
ProdList
124
Advantage
58
Chaturya Biotech (Tanuj Life Sciences)
Tel
--
Fax
--
Email
info@chaturyabiotech.com
Country
India
ProdList
398
Advantage
58
Orbit Lifescience Pvt., Ltd.
Tel
--
Fax
--
Email
orbit@orbitlifescience.com
Country
India
ProdList
206
Advantage
58
Rensun Pharmaceuticals Pvt Ltd.
Tel
--
Fax
--
Email
rensun@mtnl.net.in
Country
India
ProdList
152
Advantage
58
KPS Chemicals & Pharmaceuticals
Tel
--
Fax
--
Email
kpschempharma@gmail.com
Country
India
ProdList
240
Advantage
58
J. B. Khokhani & Co.
Tel
--
Fax
--
Email
es@jbkhokhani.com
Country
India
ProdList
34
Advantage
58
Ramdev Chemicals Pvt., Ltd.
Tel
--
Fax
--
Country
India
ProdList
9
Advantage
58
SR Farmalife Pvt. Ltd.
Tel
--
Fax
--
Email
info@srfarmalife.com
Country
India
ProdList
47
Advantage
58
Globofarm International Private Limited
Tel
--
Fax
--
Email
procurement@globofarm.net
Country
India
ProdList
188
Advantage
58
Manus Aktteva Biopharma LLP
Tel
--
Fax
--
Country
India
ProdList
655
Advantage
58
USV PRIVATE LIMITED
Tel
--
Fax
--
Email
info@usv.in
Country
India
ProdList
22
Advantage
58
Clearsynth Labs
Tel
--
Fax
--
Email
fo@clearsynth.com
Country
India
ProdList
3887
Advantage
58
Ralington Pharma
Tel
--
Fax
--
Email
info@ralingtonpharma.com
Country
India
ProdList
312
Advantage
58
Besil Chem LLP
Tel
--
Fax
--
Email
info@besilchem.com
Country
India
ProdList
65
Advantage
58
Athos Chemicals
Tel
--
Fax
--
Email
export@athoschemicals.com
Country
India
ProdList
315
Advantage
58
Shivam Pharma Chemicals
Tel
--
Fax
--
Email
info@shivampharma.com
Country
India
ProdList
656
Advantage
58
Pharma Affiliates
Tel
--
Fax
--
Email
@pharmaffiliates.com
Country
India
ProdList
6754
Advantage
58
S. Zhaveri Pharmakem Pvt. Ltd
Tel
--
Fax
--
Email
info@szhaveri.net
Country
India
ProdList
112
Advantage
58
SUVEN LIFE SCIENCES LTD
Tel
--
Fax
--
Email
info@suven.com
Country
India
ProdList
95
Advantage
58
Aadivighnesh Chem Private Ltd.
Tel
--
Fax
--
Email
sales@aadivighnesh.com
Country
India
ProdList
119
Advantage
58
Dazzle Corporation
Tel
--
Fax
--
Email
enquiry@dazzlecorporation.co.in
Country
India
ProdList
209
Advantage
58
Oceanic Pharmachem Pvt. Ltd.
Tel
--
Fax
--
Email
info@oceanicpharmachem.com
Country
India
ProdList
2005
Advantage
58
Hetero Drugs Limited
Tel
--
Fax
--
Country
India
ProdList
174
Advantage
58
Synthink Research Chemicals
Tel
--
Fax
--
Country
India
ProdList
398
Advantage
58
SynZeal Research Pvt Ltd
Tel
--
Fax
--
Email
standards@synzeal.com
Country
India
ProdList
6514
Advantage
58
RA CHEM PHARMA LTD
Tel
--
Fax
--
Email
info@rachempharma.com
Country
India
ProdList
37
Advantage
58
MACLEODS PHARMACEUTICALS LIMITED
Tel
--
Fax
--
Email
customercare@macleodspharma.com
Country
India
ProdList
60
Advantage
58
LAMRIN Labs
Tel
--
Fax
--
Email
sales@lamrin.in
Country
India
ProdList
21
Advantage
58
Dr. Jcr Bio-Sciences Private Limited.
Tel
--
Fax
--
Email
info@drjcrbio.com
Country
India
ProdList
49
Advantage
58
More
Less

View Lastest Price from Entacapone manufacturers

Hebei Yanxi Chemical Co., Ltd.
Product
Entacapone 130929-57-6
Price
US $40.00/kg
Min. Order
1kg
Purity
0.99
Supply Ability
10 tons
Release date
2023-09-08
PUSHAN INDUSTRIAL (SHAANXI) CO.,LTD
Product
Entacapone 130929-57-6
Price
US $0.00/kg
Min. Order
1kg
Purity
98% HPLC
Supply Ability
500 kgs
Release date
2024-05-15
Henan Bao Enluo International TradeCo.，LTD
Product
Entacapone 130929-57-6
Price
US $50.00/kg
Min. Order
1kg
Purity
99.9%
Supply Ability
10000MT
Release date
2023-07-25

130929-57-6, EntacaponeRelated Search:

Ethylene glycol diethyl ether Diethyl malonate Diethyl oxalate 1-Hydroxyethylidene-1,1-diphosphonic acid Mefenpyr-diethyl 4-Nitrobenzoic acid Sodium 3-nitrobenzenesulphonate Entecavir Entecavir hydrate 3,4-Dihydroxy-5-Nitrobenzoic Acid (E/Z)-3-O-Methyl Entacapone (alphaE)-alpha-[(3,4-Dihydroxy-5-nitrophenyl)methylene]-beta-oxo-1-piperidinepropanenitrile (2E)-2-Cyano-3-(3-ethoxy-4-hydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide 2-Propenamide, 2-cyano-3-(3,4-dihydroxyphenyl)-N,N-diethyl-, (2E)- TYRPHOSTIN AG 1290 Entacapone Impurity 13 Entacapone 3-b-D-Glucuronide 3,5-DINITROCATECHOL

  • (E)-2-Cyano-3-(3，4-dihydroxy-5-nitrophenyl)-N，N-diethyl-2-pmpenamide
  • Entacapone (150 mg)
  • (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enaMide
  • 2-PropenaMide,2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-, (2E)-
  • (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide
  • Entacapone (isomer E)
  • (E)-2-cyano-3-(5-(dihydroxyamino)-3,4-dioxocyclohexa-1,5-dienyl)-N,N-diethylacrylamide
  • ENTACAPONE
  • 2-cyano-3-(5-dihydroxyamino-3,4-dioxo-1-cyclohexa-1,5-dienyl)-n,n-diethyl-prop-2-enamide
  • OR-611
  • (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide
  • Comtan
  • Comtes
  • Comtess
  • ENTACAPONE F·S
  • Entacapone CRS
  • Entacapone USP/EP/BP
  • Entacapone Impurity 81
  • Entacapone Impurity 82
  • Entacapone Impurity 83
  • E Entacapone
  • Entacapone (OR611)
  • Entacapone (Y0001249)
  • EntacaponeQ: What is Entacapone Q: What is the CAS Number of Entacapone Q: What is the storage condition of Entacapone Q: What are the applications of Entacapone
  • Entacapone (1235933)
  • Well he carpenters
  • Entacapone (API)
  • (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide[OR-611
  • HSDB 8251
  • HSDB8251
  • HSDB-8251
  • 130929-57-6
  • 30929-57-6
  • C14H15N4O4
  • Histone Methyltransf
  • Intermediates & Fine Chemicals
  • Pharmaceuticals